IEEE Access,
Journal Year:
2022,
Volume and Issue:
10, P. 113073 - 113085
Published: Jan. 1, 2022
Predicting
Antimicrobial
Resistance
(AMR)
from
genomic
sequence
data
has
become
a
significant
component
of
overcoming
the
AMR
challenge,
especially
given
its
potential
for
facilitating
more
rapid
diagnostics
and
personalised
antibiotic
treatments.
With
recent
advances
in
sequencing
technologies
computing
power,
deep
learning
models
have
been
widely
adopted
to
predict
reliably
error-free.
There
are
many
different
types
AMR;
therefore,
any
practical
prediction
system
must
be
able
identify
multiple
AMRs
present
sequence.
Unfortunately,
most
datasets
do
not
all
labels
marked,
thereby
making
modelling
approach
challenging
owing
reliance
on
reliability
accuracy.
This
paper
addresses
this
issue
by
presenting
an
effective
solution,
Mask-Loss
1D
convolution
neural
network
(ML-ConvNet),
with
missing
labels.
The
core
ML-
ConvNet
utilises
masked
loss
function
that
overcomes
effect
predicting
AMR.
proposed
ML-ConvNet
is
demonstrated
outperform
state-of-the-art
methods
literature
10.5%,
according
F1
score.
model's
performance
evaluated
using
degrees
label
found
conventional
76%
score
when
86.68%
missing.
Furthermore,
was
established
explainable
artificial
intelligence
(XAI)
pipeline,
it
ideally
suited
hospital
healthcare
settings,
where
model
interpretability
essential
requirement.
IEEE/ACM Transactions on Computational Biology and Bioinformatics,
Journal Year:
2022,
Volume and Issue:
20(1), P. 625 - 636
Published: Feb. 7, 2022
Predicting
Antimicrobial
Resistance
(AMR)
from
genomic
data
has
important
implications
for
human
and
animal
healthcare,
especially
given
its
potential
more
rapid
diagnostics
informed
treatment
choices.
With
the
recent
advances
in
sequencing
technologies,
applying
machine
learning
techniques
AMR
prediction
have
indicated
promising
results.
Despite
this,
there
are
shortcomings
literature
concerning
methodologies
suitable
multi-drug
where
samples
with
missing
labels
exist.
To
address
this
shortcoming,
we
introduce
a
Rectified
Classifier
Chain
(RCC)
method
predicting
resistance.
This
RCC
was
tested
using
annotated
features
of
genomics
sequences
compared
similar
multi-label
classification
methodologies.
We
found
that
eXtreme
Gradient
Boosting
(XGBoost)
base
model
to
our
outperformed
second-best
model,
XGBoost
based
binary
relevance
by
3.3%
Hamming
accuracy
7.8%
F1-score.
Additionally,
note
models
applied
typically
unsuitable
identifying
biomarkers
informative
their
decisions;
study,
show
contributing
can
also
be
identified
proposed
method.
expect
facilitate
genome
annotation
pave
path
towards
new
indicative
AMR.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(3), P. 224 - 224
Published: Feb. 28, 2024
The
outcome
of
bacterial
infection
management
relies
on
prompt
diagnosis
and
effective
treatment,
but
conventional
antimicrobial
susceptibility
testing
can
be
slow
labor-intensive.
Therefore,
this
study
aims
to
predict
phenotypic
selected
beta-lactam
antimicrobials
in
the
bacteria
family
Enterobacteriaceae
from
different
beta-lactamase
resistance
genotypes.
Using
human
datasets
extracted
Antimicrobial
Testing
Leadership
Surveillance
(ATLAS)
program
conducted
by
Pfizer
retail
meat
National
Resistance
Monitoring
System
for
Enteric
Bacteria
(NARMS),
we
used
a
robust
or
weighted
least
square
multivariable
linear
regression
modeling
framework
explore
relationship
between
data
types
genes.
In
humans,
presence
blaCTX-M-1,
blaCTX-M-2,
blaCTX-M-8/25,
blaCTX-M-9
groups,
MICs
cephalosporins
significantly
increased
values
0.34–3.07
μg/mL,
however,
carbapenem
decreased
0.81–0.87
μg/mL.
carbapenemase
genes
(blaKPC,
blaNDM,
blaIMP,
blaVIM),
cephalosporin
1.06–5.77
while
5.39–67.38
meat,
MIC
ceftriaxone
blaCMY-2,
blaCTX-M-55,
blaCTX-M-65,
blaSHV-2
55.16
222.70
250.81
204.89
31.51
μg/mL
respectively.
cefoxitin
blaCTX-M-65
blaTEM-1
1.57
1.04
an
average
8.66
over
17
years.
Compared
E.
coli
isolates,
Salmonella
enterica
isolates
0.67
On
other
hand,
ceftiofur
blaSHV-2,
8.82
9.11
8.18
10.20
14
ability
directly
may
help
reduce
reliance
routine
with
higher
turnaround
times
diagnostic,
therapeutic,
surveillance
antimicrobial-resistant
Enterobacteriaceae.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Feb. 8, 2022
Abstract
Current
methods
for
diagnosing
acute
and
complex
infections
mostly
rely
on
culture-based
and,
biofilms,
fluorescence
in-situ
hybridization.
These
techniques
are
labor-intensive
can
take
2-4
days
to
return
a
test
result,
especially
considering
an
extra
culturing
step
required
the
antibiotic
susceptibility
testing
(AST).
This
places
significant
burden
healthcare
providers,
delaying
treatment
leading
adverse
patient
outcomes.
Here,
we
report
complementary
use
of
our
newly
developed
multi-excitation
Raman
spectroscopy
(ME-RS)
method
with
whole-genome
sequencing
(WGS).
Four
WHO
priority
pathogens
AST
phenotyped
their
antimicrobial
resistance
(AMR)
profile
determined
by
WGS.
On
application
ME-RS
find
high
correlation
WGS
characterization.
Highly
accurate
classification
based
species
(98.93%),
wild-type/non-wild
type
(99.45%),
presence
or
absence
thick
peptidoglycan
layers
in
cell
walls
(100%),
as
well
at
individual
strain
level
(99.29%).
results
clearly
demonstrate
potential
rapid
first-stage
tool
species,
strain-level
which
be
followed
up
confirmation.
Such
workflow
facilitate
efficient
stewardship
handle
prevent
spread
AMR.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: July 7, 2022
Abstract
The
current
state-of-the-art
infection
and
antimicrobial
resistance
diagnostics
(AMR)
is
based
mainly
on
culture-based
methods
with
a
detection
time
of
48-96
hours.
Slow
diagnoses
lead
to
adverse
patient
outcomes
that
directly
correlate
the
taken
administer
optimal
antimicrobials.
Mortality
risk
doubles
24-hour
delay
in
providing
appropriate
antibiotics
cases
bacteremia.
Therefore,
it
essential
develop
novel
can
promptly
accurately
diagnose
microbial
infections
at
both
species
strain
levels
clinical
settings.
Here,
we
demonstrate
complimentary
use
label-free
optical
assay
whole-genome
sequencing
(WGS)
enable
high-speed
culture-free
diagnosis
AMR.
Our
microscopy
exploiting
label-free,
highly
sensitive
quantitative
phase
(QPM)
followed
by
deep
convolutional
neural
networks
(DCNNs)
classification.
We
benchmarked
our
proposed
workflow
21
isolates
from
four
WHO
priority
pathogens
(
Escherichia
coli,
Staphylococcus
aureus,
Klebsiella
pneumoniae
,
Acinetobacter
baumannii
)
were
antibiotic
susceptibility
testing
(AST)
phenotyped,
their
profile
was
determined
WGS.
good
agreement
WGS
characterization.
Highly
accurate
classification
gram
staining
(100%
for
gram-negative
83.4%
gram-positive),
(98.6%),
resistant/susceptible
type
(96.4%),
as
well
individual
level
predicting
19
out
strains).
These
results
potential
QPM
rapid
first-stage
tool
species,
presence,
absence
AMR,
strain-level
classification,
which
follow
up
confirmation
pathogen
ID
characterization
AMR
antibiotic.
Taken
together,
all
this
information
high
importance.
Such
could
potentially
facilitate
efficient
stewardship
prevent
spread
IEEE Access,
Journal Year:
2022,
Volume and Issue:
10, P. 113073 - 113085
Published: Jan. 1, 2022
Predicting
Antimicrobial
Resistance
(AMR)
from
genomic
sequence
data
has
become
a
significant
component
of
overcoming
the
AMR
challenge,
especially
given
its
potential
for
facilitating
more
rapid
diagnostics
and
personalised
antibiotic
treatments.
With
recent
advances
in
sequencing
technologies
computing
power,
deep
learning
models
have
been
widely
adopted
to
predict
reliably
error-free.
There
are
many
different
types
AMR;
therefore,
any
practical
prediction
system
must
be
able
identify
multiple
AMRs
present
sequence.
Unfortunately,
most
datasets
do
not
all
labels
marked,
thereby
making
modelling
approach
challenging
owing
reliance
on
reliability
accuracy.
This
paper
addresses
this
issue
by
presenting
an
effective
solution,
Mask-Loss
1D
convolution
neural
network
(ML-ConvNet),
with
missing
labels.
The
core
ML-
ConvNet
utilises
masked
loss
function
that
overcomes
effect
predicting
AMR.
proposed
ML-ConvNet
is
demonstrated
outperform
state-of-the-art
methods
literature
10.5%,
according
F1
score.
model's
performance
evaluated
using
degrees
label
found
conventional
76%
score
when
86.68%
missing.
Furthermore,
was
established
explainable
artificial
intelligence
(XAI)
pipeline,
it
ideally
suited
hospital
healthcare
settings,
where
model
interpretability
essential
requirement.